Microbiology Testing Market to Reach $44.5 Billion by 2035
Microbiology testing market is driven by the increasing prevalence of infectious diseases, rising demand for rapid microbial detection technologies, and growing focus on food safety and pharmaceutical quality assurance worldwide. Expanding applications across pharmaceutical manufacturing, clinical diagnostics, food and beverage testing, environmental monitoring, and cosmetic safety testing are further accelerating market growth. In addition, advancements in automated microbiology systems, molecular diagnostic technologies, and reagent development, along with stringent regulatory standards for contamination control and product safety, are supporting the adoption of microbiology testing solutions globally.
Browse the full report description of “Microbiology Testing Market Size, Share & Trends Analysis Report by Product (Equipment, Reagents, and Others), by Test Type (Bacterial, Viral, and Fungal), and by Application (Pharmaceutical, Diagnostic, Food and Beverage Testing, Environmental, Cosmetic, and Others), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/microbiology-testing-market
Clinical microbiology diagnostics segment is expected to account for a major market share in 2026
Clinical microbiology diagnostics are expected to hold a major market share in 2026, primarily due to the increasing demand for rapid pathogen detection, antimicrobial susceptibility testing, and advanced infectious disease diagnostics across healthcare and pharmaceutical sectors. These solutions are extensively used in hospitals, diagnostic laboratories, pharmaceutical manufacturing, and food safety testing to improve microbial detection accuracy and support infection control programs. The agreement by Thermo Fisher Scientific to sell its microbiology business to Astorg for approximately US$1.08 billion in 2026 highlights the growing strategic value and ongoing restructuring within the microbiology diagnostics market. Increasing focus on laboratory modernization and rising demand for antimicrobial resistance monitoring are expected to significantly support the growth of the clinical microbiology diagnostics segment.
MALDI-TOF microbial identification systems segment is expected to account for a major market share in 2026
MALDI-TOF microbial identification systems are expected to hold a major market share in 2026 owing to the increasing adoption of rapid, high-throughput microbial identification technologies in clinical laboratories and outbreak management applications. These systems provide fast and accurate identification of bacterial and fungal species, improving diagnostic efficiency and supporting infection surveillance initiatives. The expansion of MALDI Biotyper and IR Biotyper microbiology workflows by Bruker Corporation in 2026, including new microbial identification kits, expanded species libraries covering more than 5,300 species, and cloud-based microbial identification solutions, reflects the growing industry focus on advanced microbiology automation and digital laboratory integration. Increasing demand for real-time microbial analytics and outbreak monitoring capabilities is expected to further accelerate the growth of the MALDI-TOF microbial identification systems segment.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404